Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 02/04/2012
PIL Avamys

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/04/2012 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
  • Change to side-effects
Updated on 17/11/2011 and displayed until 02/04/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 02/02/2010 and displayed until 17/11/2011
Reasons for adding or updating:
  • Change to storage instructions
  • Change to side-effects
  • Change to Further Information section
  • Change to, or new, use for medicine
Updated on 19/06/2009 and displayed until 02/02/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 13/01/2009 and displayed until 19/06/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  fluticasone furoate